Composition
- Active ingredients
- ARGATROBAN 250MG/2.5ML (100MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ARGATROBAN 250MG/2.5ML (100MG/ML) · InjectableNDA020883-001 · Discontinued
- ARGATROBAN 50MG/50ML (1MG/ML) · InjectableANDA214235-001 · Prescription
- ARGATROBAN 250MG/2.5ML (100MG/ML) · InjectableNDA201811-001 · Discontinued
- ARGATROBAN 250MG/2.5ML (100MG/ML) · InjectableThis page
- ARGATROBAN 250MG/2.5ML (100MG/ML) · InjectableANDA202626-001 · Prescription
- ARGATROBAN 250MG/250ML · InjectableNDA022359-001 · Tentative approval
- ARGATROBAN 250MG/2.5ML (100MG/ML) · InjectableANDA206698-001 · Prescription
- ARGATROBAN 100MG · InjectableANDA079238-001 · Tentative approval
- ARGATROBAN 50MG/50ML (1MG/ML) · InjectableNDA203049-002 · Prescription
- ARGATROBAN 250MG/2.5ML (100MG/ML) · InjectableNDA203049-001 · Prescription
- ARGATROBAN 250MG/2.5ML (100MG/ML) · InjectableANDA091665-001 · Prescription
- ARGATROBAN 50MG/50ML (1MG/ML) · InjectableANDA217848-001 · Prescription
At a glance
- Brand name
- Argatroban
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Hospira
- Status
- Prescription
- FDA approval
- 21 Sept 2016
- Application
- ANDA204120-001